Advertisement
UK markets close in 5 hours 20 minutes
  • FTSE 100

    8,118.23
    +39.37 (+0.49%)
     
  • FTSE 250

    19,831.32
    +229.34 (+1.17%)
     
  • AIM

    755.56
    +2.44 (+0.32%)
     
  • GBP/EUR

    1.1661
    +0.0004 (+0.04%)
     
  • GBP/USD

    1.2518
    +0.0007 (+0.05%)
     
  • Bitcoin GBP

    51,530.28
    +473.82 (+0.93%)
     
  • CMC Crypto 200

    1,390.31
    -6.23 (-0.45%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.92
    +0.35 (+0.42%)
     
  • GOLD FUTURES

    2,361.20
    +18.70 (+0.80%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,049.56
    +132.28 (+0.74%)
     
  • CAC 40

    8,041.47
    +24.82 (+0.31%)
     

What Drove Down Rite Aid’s Fiscal 4Q18 Sales?

What Drove Down Rite Aid’s Fiscal 4Q18 Sales?

As we saw in the previous part of this series, Rite Aid (RAD) reported an 8.6% YoY (year-over-year) decline in its fiscal 4Q18 revenues from continuing operations to $5.4 billion. Its Retail Pharmacy segment, which includes prescription drugs, health and beauty products, and personal care items, saw its revenue fall 10.1% to $4 billion. Same-store sales from continuing operations fell 1.7% YoY during the quarter, driven by a 2.3% decline in pharmacy sales and a 0.6% fall in front-end sales.